FDA clears Vivani Medical’s IND for NPM-119 in type 2 diabetes

Vivani Medical, Inc. (Nasdaq: VANI), a pioneer in biopharmaceutical innovations, has reached a pivotal milestone as the U.S. Food and Drug Administration (FDA) has cleared ... Read More